Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma

Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET

(2011) D. J. Straus et al.   BLOOD

The Unique Characteristics and Management of Patients Over 60 Years of Age with Classic Hodgkin Lymphoma

(2011) Teresa V. Halbsguth et al.   Current Hematologic Malignancy Reports

Comorbidity, age and overall survival in cetuximab-treated patients with advanced colorectal cancer (ACRC)--results from NCIC CTG CO.17: a phase III trial of cetuximab versus best supportive care

(2010) T. R. Asmis et al.   ANNALS OF ONCOLOGY

Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)

(2010) T. V. Halbsguth et al.   BLOOD

Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma

(2010) Andreas Engert et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hodgkin lymphoma in the elderly: A clinical review of treatment and outcome, past, present and future

(2009) S.J. Proctor et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Geriatric Oncology: How Far Have We Gone and What Are the Next Steps?

(2009) Jean-Emmanuel Kurtz et al.   ONCOLOGY